Quick Answer
Sunshine Biopharma Inc. reported Earnings Per Share Diluted of $7.32 (loss) per share for the year ending 2024.
- Sunshine Biopharma Inc. showed an increase of +97.9% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Sunshine Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Sunshine Biopharma Inc.'s Earnings Per Share Diluted has declined by 53.8%.
- Historical annual values: Fiscal year 2024: $7.32 (loss) per share | Fiscal year 2023: $351.36 (loss) per share | Fiscal year 2022: $1.76 (loss) per share | Fiscal year 2021: $4.76 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: